drugset
drugset / Trial / NCT03418610

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

NCT03418610 ↗

Phase 4 Completed 5 enrolled Clinical Research Center of the Carolinas Bayer · collab
NaSingle-groupOpen-labelTreatment

Summary

This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.

Timeline

Start
2017-12-06
Primary completion
2019-01-09
Completion
2019-01-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule 15 % Topical

Indications

rosacea